Ignite Creation Date:
2024-05-05 @ 12:03 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00221624
Status:
COMPLETED
Last Update Posted:
2007-06-13
First Post:
2005-09-13
Brief Title:
Peginterferon Alfa-2a Plus Ribavirin Plus Amantadine for the Treatment of Hepatitis C Infected Patients
Sponsor:
University Hospital Bordeaux
Organization:
University Hospital Bordeaux
Organization Data
Organization:
University Hospital Bordeaux
Class:
OTHER
Study ID:
7929-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University Hospital Bordeaux
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Hoffmann-La Roche | INDUSTRY |